Article Content

Hypoguard (Minneapolis, MN) has received FDA approval for the Advance Micro-Draw blood glucose system. This convenient system offers diabetics the option to use alternate site testing when checking their blood glucose levels. It gives patients the ability to draw a blood sample from their palm, in addition to traditional fingertip tests, offering a less painful way to measure blood glucose levels.

 

The Advance Micro-Draw system features biosensor technology and requires only a small blood sample. According to Hypoguard, its small sample size results in less painful, more comfortable testing.

  
FIGURE. No caption a... - Click to enlarge in new windowFIGURE. No caption available.

Only two simple steps are required to use the device, which produces accurate test results in just 15 seconds. Advance Micro-Draw has a large display with easy-to-read digits for patients with visual impairments. The system also provides data management capabilities, including date and time, 250-test memory, and 14-to 30-day averaging. This product is covered by Medicare.

 

For more information, visit http://www.hypoguard.com.